Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shen Lian Biomedical is a China-based animal health biotechnology company focused on veterinary biological products, especially vaccines and diagnostic products for livestock and companion animals. The company is best known for swine foot-and-mouth disease vaccines and describes itself as China’s first synthetic peptide vaccine manufacturer. Its commercial portfolio includes synthetic peptide and inactivated vaccines, recombinant subunit vaccines, veterinary diagnostic kits, and early pet biologics programs including an mRNA vaccine candidate. Shen Lian operates GMP manufacturing facilities in Shanghai and Lanzhou and is listed on the STAR Market of the Shanghai Stock Exchange. Overall, the company is an animal-health-focused biotech rather than a human therapeutics biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shen Lian Biomedical.